VERICEL CORPORATION Operating Cash Flow
VERICEL CORPORATION (VCEL) reported Operating Cash Flow of $32.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-30
- VERICEL CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $16.19M, a 97.11% increase year-over-year.
- VERICEL CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $16.38M, a 148.23% increase year-over-year.
- VERICEL CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $15.01M, a 32.50% decline year-over-year.
- VERICEL CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $22.08M, a 116.83% increase year-over-year.
- VERICEL CORPORATION net cash provided by (used in) operating activities for fiscal 2025 was $51.91M, a 10.75% decline from fiscal 2024.
- VERICEL CORPORATION net cash provided by (used in) operating activities for fiscal 2024 was $58.16M, a 64.72% increase from fiscal 2023.
- VERICEL CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was $35.31M, a 99.64% increase from fiscal 2022.
- VERICEL CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was $17.69M, a 39.09% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 267 month |
|---|---|---|---|---|---|
| 2026-06-30 | $16.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $32.57M 10-Q · filed 2026-07-30 | $47.59M derived: sum of 3 quarters · filed 2026-07-30 | $69.67M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $16.38M 10-Q · filed 2026-05-07 | $31.40M derived: sum of 2 quarters · filed 2026-05-07 | $53.48M derived: sum of 3 quarters · filed 2026-05-07 | $61.69M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $15.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $37.10M derived: sum of 2 quarters · filed 2026-02-26 | $45.31M derived: sum of 3 quarters · filed 2026-07-30 | $51.91M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $22.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $30.30M derived: sum of 2 quarters · filed 2026-07-30 | $36.90M 10-Q · filed 2025-11-06 | $59.14M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $8.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $14.81M 10-Q · filed 2026-07-30 | $37.06M derived: sum of 3 quarters · filed 2026-07-30 | $47.24M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $6.60M 10-Q · filed 2026-05-07 | $28.84M derived: sum of 2 quarters · filed 2026-05-07 | $39.03M derived: sum of 3 quarters · filed 2026-05-07 | $57.56M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $22.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.43M derived: sum of 2 quarters · filed 2026-02-26 | $50.96M derived: sum of 3 quarters · filed 2026-02-26 | $58.16M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $10.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $28.72M derived: sum of 2 quarters · filed 2025-11-06 | $35.92M 10-Q · filed 2025-11-06 | $46.01M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $18.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $25.74M 10-Q · filed 2025-07-31 | $35.82M derived: sum of 3 quarters · filed 2026-02-26 | $42.99M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $7.20M 10-Q · filed 2025-05-08 | $17.29M derived: sum of 2 quarters · filed 2026-02-26 | $24.46M derived: sum of 3 quarters · filed 2026-02-26 | $34.65M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $10.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.25M derived: sum of 2 quarters · filed 2026-02-26 | $27.45M derived: sum of 3 quarters · filed 2026-02-26 | $35.31M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $7.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $17.36M derived: sum of 2 quarters · filed 2024-11-07 | $25.23M 10-Q · filed 2024-11-07 | $32.20M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $18.06M 10-Q · filed 2024-08-01 | $25.03M derived: sum of 3 quarters · filed 2025-02-27 | $29.13M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $7.86M 10-Q · filed 2024-05-08 | $14.84M derived: sum of 2 quarters · filed 2025-02-27 | $18.94M derived: sum of 3 quarters · filed 2025-02-27 | $22.08M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.08M derived: sum of 2 quarters · filed 2025-02-27 | $14.22M derived: sum of 3 quarters · filed 2025-02-27 | $17.69M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $7.24M derived: sum of 2 quarters · filed 2023-11-08 | $10.71M 10-Q · filed 2023-11-08 | $21.26M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $3.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $6.61M 10-Q · filed 2023-08-02 | $17.16M derived: sum of 3 quarters · filed 2024-02-29 | $20.80M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $3.47M 10-Q · filed 2023-05-10 | $14.02M derived: sum of 2 quarters · filed 2024-02-29 | $17.65M derived: sum of 3 quarters · filed 2024-02-29 | $22.42M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $10.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $14.19M derived: sum of 2 quarters · filed 2024-02-29 | $18.95M derived: sum of 3 quarters · filed 2024-02-29 | $29.04M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $8.40M derived: sum of 2 quarters · filed 2022-11-09 | $18.49M 10-Q · filed 2022-11-09 | $29.83M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $4.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $14.86M 10-Q · filed 2022-08-03 | $26.19M derived: sum of 3 quarters · filed 2023-02-23 | $30.76M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $10.09M 10-Q · filed 2022-05-04 | $21.42M derived: sum of 2 quarters · filed 2023-02-23 | $25.99M derived: sum of 3 quarters · filed 2023-02-23 | $22.97M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $11.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $15.91M derived: sum of 2 quarters · filed 2023-02-23 | $12.89M derived: sum of 3 quarters · filed 2023-02-23 | $17.57M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $4.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.55M derived: sum of 2 quarters · filed 2021-11-09 | $6.24M 10-Q · filed 2021-11-09 | $9.38M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | -$3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.67M 10-Q · filed 2021-08-04 | $4.82M derived: sum of 3 quarters · filed 2022-02-24 | $12.71M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $4.69M 10-Q · filed 2021-05-05 | $7.84M derived: sum of 2 quarters · filed 2022-02-24 | $15.73M derived: sum of 3 quarters · filed 2022-02-24 | -$2.65M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $11.04M derived: sum of 2 quarters · filed 2022-02-24 | -$7.34M derived: sum of 3 quarters · filed 2022-02-24 | -$7.18M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $7.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$10.49M derived: sum of 2 quarters · filed 2020-11-05 | -$10.33M 10-Q · filed 2020-11-05 | -$7.72M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | -$18.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$18.23M 10-Q · filed 2020-08-05 | -$15.61M derived: sum of 3 quarters · filed 2021-02-24 | -$13.60M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $154.00K 10-Q · filed 2020-05-11 | $2.77M derived: sum of 2 quarters · filed 2021-02-24 | $4.78M derived: sum of 3 quarters · filed 2021-02-24 | -$663.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $4.62M derived: sum of 2 quarters · filed 2021-02-24 | -$817.00K derived: sum of 3 quarters · filed 2021-02-24 | -$412.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$3.43M derived: sum of 2 quarters · filed 2019-11-05 | -$3.02M 10-Q · filed 2019-11-05 | -$2.19M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | -$5.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$5.04M 10-Q · filed 2019-08-06 | -$4.20M derived: sum of 3 quarters · filed 2020-02-25 | -$9.44M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $405.00K 10-Q · filed 2019-05-07 | $1.24M derived: sum of 2 quarters · filed 2020-02-25 | -$4.00M derived: sum of 3 quarters · filed 2020-02-25 | -$9.66M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $834.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$4.41M derived: sum of 2 quarters · filed 2020-02-25 | -$10.06M derived: sum of 3 quarters · filed 2020-02-25 | -$13.18M 10-K · filed 2020-02-25 | |
| 2017-09-30 | -$5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$10.89M derived: sum of 2 quarters · filed 2018-11-06 | -$14.02M 10-Q · filed 2018-11-06 | -$23.32M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | -$5.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$8.78M 10-Q · filed 2018-08-06 | -$18.08M derived: sum of 3 quarters · filed 2019-02-26 | -$22.27M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | -$3.12M 10-Q · filed 2018-05-08 | -$12.43M derived: sum of 2 quarters · filed 2019-02-26 | -$16.61M derived: sum of 3 quarters · filed 2019-02-26 | ||
| 2016-12-31 | -$9.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$13.49M derived: sum of 2 quarters · filed 2019-02-26 | -$19.89M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | -$4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$10.58M 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | -$6.40M 10-Q · filed 2017-08-09 | ||||
| 2015-12-31 | -$13.35M 10-K · filed 2018-03-05 | ||||
| 2011-06-30 | -$12.21M 10-Q · filed 2011-08-15 | -$214.79M 10-Q · filed 2011-08-15 | |||
| 2010-06-30 | -$7.88M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |